Epirubicin hydrochloride

Epirubicin hydrochloride


Epirubicin hydrochloride is a semisynthetic L-arabino derivative of doxorubicin that inhibits Topoisomerase, DNA/RNA synthesis, and Foxp3, reducing regulatory T cell activity. A stereoisomer of doxorubicin, it undergoes β-glucuronidation, mitigating dose-limiting side effects. It is cytotoxic to HeLa cells (ID50 = 9 μM) and has shown efficacy alone or in combination therapies across various cancers, including breast, ovarian, lymphoma, pancreatic, gastric, and colorectal cancers.

Molecular structure of the compound BP-43652
    • Unit
    • Price
    • Qty
    • 50 MG
    • $210.00
    • 100 MG
    • $320.00
    • 250 MG
    • $540.00
    • 500 MG
    • $780.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire